Member access

4-Traders Homepage  >  Shares  >  Mercato Continuo Espanol  >  Grifols SA    GRF   ES0171996012

GRIFOLS SA (GRF)

46
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mercato Continuo Espanol
08/25/2014 08/26/2014 08/27/2014 08/28/2014 08/29/2014 Date
35.48(c) 35.57(c) 35.6(c) 35.495(c) 35.43(c) Last
853 703 1 001 559 544 843 772 416 701 941 Volume
+2.23% +0.25% +0.08% -0.29% -0.18% Change
More quotes
Company
Grifols SA operates as a fractionator of plasma derived blood products. The company operates through four segments: Bioessence, Hospital, Diagnostic and Raw Materials. The Bioessence segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital... 
Sector
Pharmaceuticals
Calendar
10/29Earnings Release
Surperformance© rating of Grifols SA
Trading Rating : Investor Rating :
More about the company
Chart GRIFOLS SA
Duration : Period :
Grifols SA Technical Analysis Chart | GRF | ES0171996012 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 3 471 M
EBIT 2014 923 M
Net income 2014 490 M
Debt 2014 3 146 M
Yield 2014 1,57%
Sales 2015 3 694 M
EBIT 2015 999 M
Net income 2015 548 M
Debt 2015 2 891 M
Yield 2015 1,86%
PER 2014 24,11
PER 2015 21,23
EV / Sales 2014 4,21x
EV / Sales 2015 3,89x
Capitalization 11 482 M
More Financials
Latest news on GRIFOLS SA
08/14 ARADIGM : Announces Second Quarter 2014 Financial Results
07/31 GRIFOLS : rsquo; net profit rises by 23% to 224.8 million euros in the First Hal..
07/28 HOLOGIC : GRIFOLS -New highly sensitive test to screen donors of blood, tissues,..
07/25 GRIFOLS : New highly sensitive test to screen donors of blood, tissues, and orga..
07/10 GRIFOLS : Therapeutics Assigned Patent
07/01 GRIFOLS : Award Winners at the Seventh Edition of the Martín Villar Research Awa..
06/30 GRIFOLS : improves safety of transfusions with its ID CORE XT diagnostic kit
06/30 GRIFOLS : Therapeutics Assigned Patent
06/23 GRIFOLS : launches a continuing education program for transfusion medicine profe..
06/18 GRIFOLS : opens state-of-the-art facility in Clayton, NC to help advance treatme..
06/14 ARADIGM : Reports Milestone Payment for Dosing of First Patient in Phase III Stu..
06/11 ARADIGM : Receives $5 Million Milestone For Dosing of the First Patient in Phase..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
Grifols SA : Income Statement Evolution
More Financials
EPS Revisions
Grifols SA : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF